Results 131 to 140 of about 2,830,094 (317)

Myeloid Growth Factors [PDF]

Journal of the National Comprehensive Cancer Network, 2011
Jeffrey, Crawford, Jeffrey, Allen, James, Armitage, Douglas W, Blayney, Spero R, Cataland, Mark L, Heaney, Sally, Htoy, Susan, Hudock, Dwight D, Kloth, David J, Kuter, Gary H, Lyman, Brandon, McMahon, David P, Steensma, Saroj, Vadhan-Raj, Peter, Westervelt, Michael, Westmoreland   +15 more
openaire   +2 more sources

Investigating the cell of origin and novel molecular targets in Merkel cell carcinoma: a historic misnomer

Molecular Oncology, EarlyView.
This study indicates that Merkel cell carcinoma (MCC) does not originate from Merkel cells, and identifies gene, protein & cellular expression of immune‐linked and neuroendocrine markers in primary and metastatic Merkel cell carcinoma (MCC) tumor samples, linked to Merkel cell polyomavirus (MCPyV) status, with enrichment of B‐cell and other immune cell
Richie Jeremian, Sriraam Sivachandran, Melissa Galati, Brandon Ramchatesingh, Hibo Rijal, Johnny Hanna, Elena Netchiporouk, May Chergui, Margaret Redpath, Samy Abou Setah, Ivan V. Litvinov   +10 more
wiley   +1 more source

Integrated genomic and proteomic profiling reveals insights into chemoradiation resistance in cervical cancer

Molecular Oncology, EarlyView.
A comprehensive genomic and proteomic analysis of cervical cancer revealed STK11 and STX3 as a potential biomarkers of chemoradiation resistance. Our study demonstrated EGFR as a therapeutic target, paving the way for precision strategies to overcome treatment failure and the DNA repair pathway as a critical mechanism of resistance.
Janani Sambath, Irene A. George, Srikanth S. Manda, Prasanth Ariyannur, Ekta R. Dhawale, Raja Sekhar Kommu, Rajan Datar, Darshana Patil, Vinita Trivedi, Manisha Singh, Kumar Prabhash, Sewanti Limaye, Richa Chauhan, Prashant Kumar   +13 more
wiley   +1 more source

Increased Extraocular Muscle Strength with Direct Injection of Insulin-like Growth Factor-I

, 2006
Brian C. Anderson, Stephen P. Christiansen, Steven Grandt, Robert W. Grange, Linda K. McLoon   +4 more
openalex   +2 more sources

YAP1::TFE3 mediates endothelial‐to‐mesenchymal plasticity in epithelioid hemangioendothelioma

Molecular Oncology, EarlyView.
The YAP1::TFE3 fusion protein drives endothelial‐to‐mesenchymal transition (EndMT) plasticity, resulting in the loss of endothelial characteristics and gain of mesenchymal‐like properties, including resistance to anoikis, increased migratory capacity, and loss of contact growth inhibition in endothelial cells.
Ant Murphy, Samuel Hartzler, Paula A. Vargas Carranza, Shyaman Jayasundara, Madison E. Yates, Nimod D. Janson, Bozhi Liu, Annaleigh Benton, Majid Kazemian, Jason A. Hanna   +9 more
wiley   +1 more source

Editorial: Cell Signaling in Tumors of Endocrine and Endocrine-Responsive Tissues

Frontiers in Endocrinology, 2019
Claire Perks, Angela Hague
doaj   +1 more source

The role of fibroblast growth factors in cell and cancer metabolism. [PDF]

FEBS Lett
Price J, Francavilla C.
europepmc   +1 more source

Emerging role of ARHGAP29 in melanoma cell phenotype switching

Molecular Oncology, EarlyView.
This study gives first insights into the role of ARHGAP29 in malignant melanoma. ARHGAP29 was revealed to be connected to tumor cell plasticity, promoting a mesenchymal‐like, invasive phenotype and driving tumor progression. Further, it modulates cell spreading by influencing RhoA/ROCK signaling and affects SMAD2 activity. Rho GTPase‐activating protein
Beatrice Charlotte Tröster, Melanie Kappelmann‐Fenzl, Anja Katrin Bosserhoff, Nicole Rachinger   +3 more
wiley   +1 more source

Diagnostic applicability of the circulating growth factors in preeclampsia. [PDF]

Sci Rep
Kim HY, Moon S, Song KH, Kim HJ.
europepmc   +1 more source

First- vs second-line CDK 4/6 inhibitor use for patients with hormone receptor positive, human epidermal growth-factor receptor-2 negative, metastatic breast cancer in the real world setting [PDF]

Gretchen Kimmick, Asal Pilehvari, Wen You, Gloribel Bonilla, Roger T. Anderson   +4 more
openalex   +1 more source